Keyword
Menu
Home
About
Introducing Spineopedia
How We Score
Editors
Study Reviews
Resources
Spine Meetings
Calendar
Contact
Efficacy and Safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1 year follow-up
Share
Posted:
April 10, 2021 at 8:04 pm / by
admin
/
comments (0)
tags:
Keyword
Recent Comments
Recent Comments